KWON, HYUK JIN,권혁진,JUN, DAE WON,전대원,CHO, WON KYEONG,조원경
申请号：
KR1020120034776
公开号：
KR1011847250000B1
申请日:
2012.04.04
申请国别(地区):
KR
年份:
2012
代理人:
摘要：
PURPOSE: A pharmaceutical composition containing sarpogrelate is provided to suppress hepatic stellate cell activation and to prevent or treat liver fibrosis or liver cirrhosis. CONSTITUTION: A pharmaceutical composition for preventing or treating liver cirrhosis or liver fibrosis contains 0.01-100 wt% of sapogrelate or pharmaceutically acceptable salt thereof and pharmaceutically acceptable carrier. The pharmaceutically acceptable salt is hydrochloride. The pharmaceutical composition is manufactured in the form of a tablet, capsule, granule, fine subtilae, powder, suppository, ointment, injection, emulsion, suspension, syrup, and spray.본 발명은 사포그릴레이트 또는 그의 약제학적으로 허용되는 염 및 약제학적으로 허용되는 담체를 포함하는 간섬유화 또는 간경변의 치료 또는 예방용 약제학적 조성물을 제공한다.
